Introduction
Glial cells are highly specialized support cells in the nervous system. They exert their functions by closely associating with neuronal synapses, axons, dendrites, and soma (3).
Glial cell processes can also reach out to more distant regions such as blood vessels, the pia mater, and the vitreous humor. Astrocytes are a particular subset of glial cells whose primary function lies in the control of the ionic and osmotic composition of the extracellular environment. Physiological analyses have revealed that astrocytes possess a large K + conductance (4, 5) which is thought to be involved in the polarized transport interfere with neuronal excitability (5, 6) . Because an inwardly rectifying K + (Kir) channel subunit, Kir4.1, and a water channel, AQP4, are found closely co-localized on specific membrane domains of astrocytes and Müller cells, it is assumed that the K + -buffering is also essential for neural osmotic homeostasis by coupling with water movement (7) (8) (9) (10) (11) (12) (13) .
It has been proposed that Kir4.1 is a major component of the K + conductance in brain astrocytes and retinal Müller cells (14) (15) (16) (17) . A recent immunohistochemical study of the retina has revealed that Müller cells express not only homomeric Kir4.1 but also heteromeric Kir4.1/5.1 channels (18) .
The two Kir channels distributed differentially within a Müller cell. They also have different biophysical properties and intracellular pH (pH i )-dependence (1, 2, 19) . It is therefore suggested that the two Kir channels play distinct functional roles in the buffering of K + : the homomeric Kir4.1 localized at end feet facing the vitreous surface and at processes wrapping blood vessels may allow K + extrusion, while heteromeric Kir4.1/5.1 channels at processes surrounding neurons may be responsible for pH i -dependent K + uptake. Although it was shown that Kir5.1 subunit was abundantly expressed in the brain as well (20, 21) ,
little is known about its role in formation of brain Kir channel and its precise distribution.
In the present study, we compared the biochemical and immunological properties of brain Kir5.1 and Kir4.1. We found that the Kir subunits form at least two types of channels, heteromeric Kir4.1/5.1 and homomeric Kir4.1, in the brain. Both Kir channels were expressed in astrocytes but not in neurons. Within an astrocyte, each type of Kir channel distributed to specific membrane domains, i.e. perivascular or perisynaptic area, in a region-specific manner. We also found that Kir4.1/5.1 and Kir4.1 channels could bind syntrophins, which are components of the dystrophin-associated protein complex (DAPC). Since the DAPC has been proposed to be responsible for the polarized distribution of Kir4.1 in Müller cells (22, 23) , syntrophins may be at least partially involved in the targeting of the Kir channels to specific membrane domain in astrocytes. Taken together, our results suggest that the assembly of Kir5.1 with Kir4.1 conveys particular properties to the K + -buffering action of astrocytes in various areas of the brain.
Experimental procedures

Antibodies
Generation of specific antibodies against Kir4.1 (K AB -2C2) and Kir5.1 (Kir5.1-NR1) was as previously described (18, 24) . Antibodies specific for Kir4.2 (epitope: residues 347-366 of mouse Kir4.2, Genbank accession number O88932) and AQP4 (epitope:
residues 249-323 of rat AQP4, P47863) were purchased from Alomone labs (Jerusalem, Israel).
Preparation of membrane fractions and Western blotting
Membrane fractions of kidney and brain were prepared as described elsewhere (25) .
Briefly, whole brain and kidney cortex of adult female C57BL/6 mice (7~8 weeks old)
were homogenized in 9 volumes of dissecting buffer (0.3 M sucrose, 25 mM imidazole, 1 mM EDTA, pH7.2) containing a protease inhibitor cocktail (Roche, Mannheim, Germany). The homogenate was centrifuged at 4,000 g for 15 min to remove nuclei, mitochondria, and any remaining large cellular fragments. The supernatant was further centrifuged at 17,000 g for 30 min. The pellet was harvested as a membrane fraction.
The membrane protein was then heated for 10 min at 70°C in the sample buffer containing β-mercaptoethanol, and analyzed by SDS-PAGE and immunoblotting with anti-Kir4.1, anti-Kir4.2, or anti-Kir5.1 antibody.
Deglycosylation and inhibition of glycosylation
Extracellular glycocalyx moieties were removed from brain and renal membrane proteins (deglycosylation) by dilution of 40 µg protein in a buffer containing 20 mM sodium phosphate, 10 mM EDTA, and 0.5% Nonidt P40 (pH7.2) and incubated with N-glycosidase F (Roche) for 17 hrs at 37°C. The proteins were directly analyzed using Western blotting.
In some cases, glycosylation of transiently expressed Kir4.1 and Kir4.2 protein (HEK293T) was inhibited by supplementing the culture medium with 1.5 µg/ml tunicamycin (Sigma, St. Louis, MO) for 15 hrs. The cells were harvested, lysed by a solution containing 1% Triton X-100, 0.5% deoxycholic acid, and 150 mM NaCl in 40 mM Tris-HCl at pH 7.4, and finally analyzed by Western blotting.
Tissue culture and immunoprecipitation
Using Lipofectamine (Gibco BRL, Rockville, MD) according to the manufacturer's protocol, we transiently transfected HEK293T cells with full-length cDNA of either Bacteria were sonicated in lysis buffer, centrifuged, the lysates recovered, and the fusion proteins purified on glutathione-sepharose.
Pulldown assays were done as previously described (27 with 30 µl of glutathione-sepharose beads bound to 5 µg of purified fusion protein.
Samples were washed four times at room temperature with the same buffer. The materials retained on the beads were eluted with sample-buffer solution and analyzed by SDS-PAGE and immunoblotting using anti-GFP or anti-Kir5.1 antibody.
Immunohistochemistry
All of the brain samples for immunohistochemistry were prepared as previously described (28, 29) . Briefly, the bodies of adult female C57BL/6 mice, which were deeply anesthetized with pentobarbital sodium (100 mg/kg), were perfused from their left ventricle with 4% paraformaldehyde/0.1 M sodium phosphate, pH7.4, and the brains were isolated. The procedures for double-immunolabeling of slice sections have been previously published (14, 16, 30, 31) . In short, cryosections of brain (12 µm) were at first incubated with anti-Kir5.1 (4 µg/ml; Figs. 2 and 3A) or anti-Kir4.1 (0.3 µg/ml; 
Immunoelectron microscopic examination
Pre-embedding immunoelectron microscopic analysis of mouse brain with either Kir4.1 or Kir5.1 antibody was performed as described previously (16) . Anti-Kir4.1 (6 µg/ml) or anti-Kir5.1 (40 µg/ml) was used to examine thin sections (thickness: 75~90 nm) of mouse brain neocortex. Resulting immunoreactivity was visualized by the Vectastain Elite ABC kit (Vector laboratories, Burlingame, CA) and 3,3'-diaminobenzidine.
Results
Biochemical characterization of brain Kir4.1 and Kir5.1
We first examined the expression of Kir4.1 and Kir5.1 in the mouse brain using antibodies of established specificity (18, 24) . In some experiments we also examined the renal expression of Kir4.1 and Kir5.1 for comparison (1, 2, 32) .
In brain preparations, the anti-Kir4.1 antibody visualized four protein bands at ~40, ~80, ~160, and ~250-kDa in the SDS-PAGE (Fig. 1Aa , lane 1). The molecular weight of the lowest band (~40-kDa) was almost identical to the predicted weight of the Kir4.1 subunit based on its cDNA length (~42-kDa), suggesting that this band represented monomeric Kir4.1. Kir channels are tetrameric and it is likely that thẽ 80-kDa and the ~160-kDa fragments correspond to complexes of two and four Kir subunits which contain at least one Kir4.1 subunit. The heaviest fragment (~250-kDa) may represent a macro protein-complex containing Kir4.1 (17, 22) . A slightly different pattern was found in human embryonic kidney (HEK293T) cells transfected with Kir4.1 cDNA (Fig. 1Ad) . In addition to the bands at ~80, ~160, and ~250-kDa (data not shown), two bands appeared at ~33 and ~38-kDa (Fig 1Ad, lane 1 ) rather than at 40-kDa corresponding to the putative brain Kir4.1-monomer (Fig. 1Ad, lane 3 ).
Kir4.1 possesses an N-glycosylation motif in its extracellular domain (33) and the degree of glycosylation may alter the mobility of the protein on gels. Preincubation of the transfected cells with tunicamycin, a glycosylation inhibitor, abolished the ~38-kDa fragment and enhanced the band at ~33-kDa (Fig. 1Ad, lane 2) . Treatment of brain protein fractions with a deglycosylation agent, N-glycosidase, shifted some of thẽ 40-kDa fragment to ~33-kDa (Fig. 1Ad, lane 4) . We therefore conclude that the band at ~40-kDa in the brain preparation and the ~38-kDa band from Kir4.1-transfected HEK293T cells represent monomeric Kir4.1 subunits. The deglycosylated Kir4.1-monomers showed faster electrophoretic mobility (~33-kDa) than that predicted from its molecular weight (~42-kDa).
Control experiments conducted in the kidney showed that the anti-Kir4.1 antibody detected several fragments at ~50-kDa, but no bands corresponding to the multimers observed in the brain (Fig. 1Aa, lane 3) . Glycosylation inhibitors reduced Kir4.1-immunoreactivity in the kidney from ~50-kDa to ~33-kDa (Fig. 1Aa, lane 4) .
Glycosylation of Kir4.1 was thus notably higher in the kidney.
On the other hand, immunoanalysis of Kir5.1-protein in the brain and kidney yielded only one clear band at ~36-kDa (Fig. 1Ab) . This was considerably smaller than the estimated size of Kir5.1 based on its cDNA length (~46-kDa). Similarly, we found only one band at ~36-kDa in preparations from HEK293T cells transfected with Kir5.1 cDNA (data not shown).
The Kir4.2 channel subunit is known to couple with Kir5.1 in the kidney (Fig.   1Ac , lane 2) (34, 35) . But in the brain we detected no significant signal for Kir4.2 protein (Fig. 1Ac, lane 1) although its mRNA has been reported to be expressed (36) .
On SDS-PAGE, the Kir4.2 protein expressed in HEK293T cells was detected at ~37
and ~35-kDa and in kidney at ~45, ~37, and ~35-kDa (Fig. 1Ae, lanes 1 and 3, respectively). Like Kir4.1, Kir4.2 possesses a glycosylation motif (34, 37 and tetramers (~160-kDa) (Fig. 1Ba, lane 3 ), these were not recognized by the antiKir5.1 antibody (Fig. 1Bb, lane 3) . Immunoreactivity for Kir5.1 in the Kir5.1-antibody precipitants could only be detected at gel positions consistent with monomeric Kir5.1 (Fig. 1Bb, lane 4) . This single band was also recognized in the precipitants with the anti-Kir4.1 antibody when they were probed with anti-Kir5.1 antibody (Fig. 1Bb, lane 3, wide solid arrowhead). No Kir4.1-immunoreactivity at ~80 or ~160-kDa was detected in the immunoprecipitants with anti-Kir5.1 antibody (Fig. 1Ba, lane 4 We therefore compared the distribution of Kir5.1 in mouse brain with that of Kir4.1 by double-immunolabeling (Fig. 2) .
Strong labeling for Kir4.1 (red) and Kir5.1 (green) was detected in the neocortex ( Fig. 2A) , with notable overlaps in various regions (yellow), especially around the blood vessels (arrows) as well as deep in the pia mater (arrowheads).
Co-localization of Kir4.1 and Kir5.1 was also detected in astrocytes of other regions, such as the pontine nucleus and the cranial nerve nuclei of the hindbrain (data not shown). Double-immunolabeling with anti-Kir4.1 and anti-Kir5.1 antibodies produced yellow signals on the inside and at the edges of the olfactory glomeruli (Fig.   2B ). Careful examination of the images revealed that the outside of the glomeruli (arrowheads) was primarily labeled by anti-Kir4.1, with only a weak signal for Kir5.1.
We next examined the CA1 region of the hippocampus (Fig. 2C ). Kir4.1 was moderately expressed in the processes of astrocytes in the pyramidal cell layer and the stratum radiatum (16, 17) . Relatively weak labeling for Kir5.1 was scattered in or close to the pyramidal cell layer, where it was largely co-localized with the Kir4.1-specific signal. In stratum radiatum, although little Kir5.1-immunoreactivity was detected, Kir4.1 and Kir5.1-labeling again appeared to be co-localized around blood vessels. In the mediorostral region of the lateral post-thalamic nucleus (Fig. 2D) , we only detected labeling for Kir4.1 and not for Kir5.1.
The expression of AQP4 in the brain is restricted to astrocyte membranes facing blood vessels or synaptic terminals (13, 38) . We compared immunolabeling for either Kir4.1 or Kir5.1 with a specific antibody for AQP4 (Fig. 3A) in the neocortex where Kir4.1 and Kir5.1 subunits were abundantly expressed (see Fig. 2A ).
Immunolabeling for AQP4 (red) was closely associated with the pial surface (arrowheads) and blood vessels (arrows). Double-labeling of AQP4 and either antiKir4.1 or anti-Kir5.1 antibody (Fig. 3A , left and right, respectively, both green) gave rise to intensive yellow labeling in both cases. This suggests the co-localization of heteromeric Kir4.1/5.1 and AQP4 in the processes of these astrocytes.
Localization of Kir4.1 and Kir5.1 in astrocytes
The localization of Kir5.1 and Kir4.1 in astrocytes of the mouse neocortex was examined by immunoelectron microscopy (Figs. 3Ba-c) . Immunolabeling for Kir4.1 was prominently detected in the perivascular processes of astrocytes (Fig. 3Ba, left) .
The pattern of Kir5.1-labeling was similar to that of Kir4.1 (Fig. 3Ba, right (Fig. 4) .
Glutathione beads charged with GST-fusion proteins containing the PDZ domain of α, β 1 , β 2 , or γ 1 -syntrophin were incubated with lysates of HEK293T cells expressing GFP-tagged constructs of Kir4.1 or Kir5.1 (Fig. 4A) . Bound proteins were analyzed by Western blotting with anti-GFP antibody. Kir4.1 subunits interacted with the PDZ domains of all but one (γ 1 ) of the syntrophins tested (Fig. 4Aa, top) . Kir5.1, by contrast, failed to bind any of the syntrophin constructs (Fig. 4Ab, bottom) , despite its known ability to associate with the PDZ domain of PSD-95 (21).
We next examined whether the Kir subunits could bind to full-length α-syntrophin. HEK293T cells were transiently transfected with either Kir4.1 or Kir5.1 in the presence or absence of myc-tagged full-length α-syntrophin, and the cell lysates were used for immunoprecipitation (Figs. 4Ab and 4Ac ). Anti-myc antibodies precipitated Kir4.1 when it was co-expressed with myc-syntrophin (Fig. 4Ab, lane 3) , but failed to do so from lysates of cells expressing Kir4.1 alone (Fig. 4Ab, lane 2) .
Kir5.1 could not be precipitated by the anti-myc antibody even when co-expressed with myc-syntrophin (Fig. 4Ac, lane 3 ). These results demonstrate that Kir4.1, but not Kir5.1, could interact with full-length α-syntrophin.
We next attempted to map the syntrophin interaction site within Kir4.1 (Fig.   4B ). The GST-syntrophin fusion proteins mentioned above were incubated with lysates of HEK293T cells transfected with a GFP-Kir4.1 construct lacking the last three carboxy-terminal amino acids (GFP-Kir4.1∆C3). None of the tested syntrophin PDZ domains precipitated GFP-Kir4.1∆C3 (Fig. 4B, lanes 3 and 4) . Thus, Kir4.1 interacts with syntrophins through its carboxy-terminal PDZ domain binding motif (amino acid residues 377-379, Ser-Asn-Val, GenBank accession number NM_002241).
However, GFP-Kir4.1∆C3 could still assemble with the Kir5.1 subunit since it could be immunoprecipitated by anti-Kir5.1 antibody (Fig. 4B , lane 5) and pulldown of syntrophin GST-fusion proteins showed that co-expression of GFP-Kir4.1
and GFP-Kir5.1 resulted in complexing of Kir5.1 with syntrophin (Fig. 4Ca, lanes 3 and 4, Kir5.1-specific antibody). By the same token, immunoprecipitation of mycsyntrophin using lysates from the cells co-expressing Kir4.1 and Kir5.1 confirmed that all three proteins were in the same complex (Fig. 4Cb, lane 3) . Therefore, homomeric
Kir4.1 and heteromeric Kir4.1/5.1 channels can associate with α and β-syntrophins.
Discussion
Heteromeric Kir4.1/5.1 and homomeric Kir4.1: distinct channel localization argues for physiological relevance
This study shows that Kir5.1 forms a functional Kir channel with Kir4.1 in brain astrocytes which is not expressed in neurons (Figs. 2 and 3 ). The distribution of Kir5.1-immunoreactivity is largely consistent with that of its mRNA (20) , although the mRNA was found also in some neurons. Homomeric assembly of Kir5.1 was not confirmed in this study, while homomeric Kir4.1 channels were identified. Therefore, the glial K + conductance, which is responsible for K + -buffering in the brain, is mainly composed of two types of Kir channels, homomeric Kir4.1 and heteromeric Kir4.1/5.1.
These Kir channels, which are differentially distributed in the brain (see Fig. 2 
Syntrophins may be involved in the targeting of glial Kir channels
The present study showed that, in brain astrocytes, heteromeric Kir4.1/5.1 channels locate predominantly at the perivascular processes, while either Kir4.1/5.1 or homomeric Kir4.1 does so at the perisynaptic processes. Therefore, the divergent mechanisms may control the targeting of the homomeric Kir4.1 and heteromeric Kir4.1/Kir5.1 channels to specific membrane domains within an astrocyte.
An essential role of DAPC in targeting of homomeric Kir4.1 channels to end feet and perivascular processes in retinal Müller cells is indicated in the cultured cells (14, 55) and mdx 3Cv mice whose dystrophin gene was chemically disrupted (22) . It is, some, but not all, of the α-syntrophin-knockout mice (α-Syn -/-) exhibited modest defects in Kir4.1-expression (58). Thus, α-syntrophin may be at least partly involved in but not be exclusively responsible for the trafficking of Kir4.1-containing channels in the brain. Other factors and/or molecules, such as β 1 and β 2 -syntrophins that we found bind to the channels (Fig. 4) , and also the constituents of DAPC other than syntrophins, may be additionally or alternatively required for the process. Further studies are needed to elucidate the precise sorting mechanisms of the glial Kir channels. 
